Related Experiment Video

Updated: Aug 19, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Prednisone therapy of membranoproliferative glomerulonephritis in children

B A Warady, S J Guggenheim, A Sedman

    The Journal of Pediatrics
    |November 1, 1985
    PubMed

    Insights

    Prednisone therapy improved kidney function in children with type 1 membranoproliferative glomerulonephritis (MPGN). Early treatment reduced proteinuria and normalized creatinine clearance, showing positive clinical outcomes over nearly 5 years.

    Area of Science:

    • Pediatric Nephrology
    • Glomerular Diseases

    Background:

    • Type 1 membranoproliferative glomerulonephritis (MPGN) is a serious kidney condition in children.
    • Nephrotic syndrome and impaired kidney function are common presentations of MPGN.

    Purpose of the Study:

    • To evaluate the clinical efficacy of prednisone therapy in children with biopsy-proven type 1 MPGN.
    • To assess the long-term impact of early prednisone treatment on kidney function and disease activity.

    Main Methods:

    • Six children with type 1 MPGN received a 2-year course of prednisone therapy.
    • Dosages were adjusted based on clinical improvement.
    • Repeat kidney biopsies and creatinine clearance measurements were performed.

    Main Results:

    • Five out of six children showed decreased glomerular disease activity on repeat biopsy.
    • All children achieved creatinine clearance greater than 120 ml/min/1.73 m2 after a mean follow-up of 5 years.
    • Proteinuria diminished, and only one child remained nephrotic.

    Conclusions:

    • Early prednisone therapy can lead to significant clinical improvement in children with type 1 MPGN.
    • The treatment resulted in sustained normalization of kidney function and reduced proteinuria.
    • While controversial, prednisone shows promise for managing pediatric MPGN when initiated early.

    More Related Videos

    Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro14:18

    Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro

    Published on: October 13, 2023

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

    Published on: August 23, 2024

    Related Concept Videos

    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

    Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Nephrotic Syndrome I : Introduction01:24

    Nephrotic Syndrome I : Introduction

    Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
    Nephrotic Syndrome II : Assessment and Medical Management01:26

    Nephrotic Syndrome II : Assessment and Medical Management

    IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
    Nephrotic Syndrome III : Nursing Management01:24

    Nephrotic Syndrome III : Nursing Management

    Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
    Kidney Transplant II: Surgical Procedure01:26

    Kidney Transplant II: Surgical Procedure

    Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...